Blockchain Registration Transaction Record
Calidi Biotherapeutics Pioneers Cancer Treatment with Engineered Viruses
Calidi Biotherapeutics innovates with engineered viruses for cancer treatment, targeting 35 million annual diagnoses by 2050. A breakthrough in genetic medicine.

This news is crucial as it highlights a potential breakthrough in cancer treatment, a disease affecting millions worldwide. Calidi Biotherapeutics' innovative approach could significantly improve the efficacy and safety of cancer therapies, offering hope to patients with primary and metastatic tumors. The company's work underscores the importance of genetic medicine in addressing the growing global cancer burden, making this development highly relevant to patients, healthcare providers, and investors in the biotech sector.
Blockchain | Details |
---|---|
Contract Address | 0xeA2912a8DA1CD48401b10cB283585874d98098F4 |
Transaction ID | 0xf6b2ee772c3e2466cd3b4f776e332e3ccfc8037074c728f8fd548f49f0e90255 |
Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
Chain | polygon-main |
NewsRamp Digital Fingerprint | meanGgHB-cff49a181651eb9131a7b5d148342766 |